SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
1. Faruqi & Faruqi investigates claims against Elevance for misleading statements. 2. Investors face losses from improper guidance on Medicaid expenses. 3. Stock price dropped significantly following negative earnings disclosures. 4. Deadline for lead plaintiff role is July 11, 2025. 5. Elevance's EPS guidance lowered due to unexpected Medicaid costs.